PIII P3 Health Partners P/S Multiple

Corporate company logo of P3 Health Partners, Inc. (PIII)

P3 Health Partners Inc. (PIII) attracts qualified medical professionals and analysts through a privilege system. Long-term contracts with insurance companies ensure a stable income stream. However, rising clinic costs have limited operating leverage, as confirmed by the revenue multiple. The current status is 0.00, while the coefficient dynamics on this chart help assess the level of investor confidence in the company's sales.

P/S Multiple: P3 Health Partners (PIII) for 07/04/2022 - 11/13/2026

Analytical breakdowns for P3 Health Partners Inc.

- stock value and consensus price forecast:
Stock Price p3hp.org|PIII - Fair Value Consensus
- market capitalization data:
Market Capitalization P3 Health|PIII - Total Enterprise Value
- balance sheet equity data:
Book Value per Share P3 Health Partners|PIII - Book Capitalization|Market Value to Book Value Ratio p3hp.org|PIII - Aggregate Company Assets
- company total debt and liquidity indicators:
Total Debt to Equity Ratio P3 Health Partners Inc.|PIII - Long-Term Loans to Capital Ratio|Short-Term Debt to Capital p3hp.org|PIII - Aggregate Debt Obligations|Debt to Book Value P3 Health|PIII - Company Long-Term Loans and Borrowings|Company Short-Term Debt P3 Health Partners|Quick Ratio p3hp.org
- company profitability and valuation multiples indicators:
PIII - Net Profit|Expected Profit P3 Health Partners Inc.|PIII - Company Value to Net Income|Projected Price to Earnings p3hp.org|PIII - Company Value to Earnings Growth Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization P3 Health|PIII - Operating profit before amortization|Net earnings per share (EPS TTM) P3 Health Partners|PIII - Net earnings per one share for the last twelve months|Year-over-year earnings per share growth for the last twelve months p3hp.org|PIII - Earnings per share increase in current year|Net earnings per share growth forecast for next year P3 Health Partners Inc.
- issuer revenue and sales details:
PIII - Company Gross Revenue|Company Future Sales Volume p3hp.org|PIII - Market Capitalization-to-Revenue Ratio|Forward P/S Multiple P3 Health
Basic company analysis:PIII (P3 Health Partners, Inc.)
Original product of P3 Health Partners Inc.

An analysis of the price-to-sales ratio for P3 Health Partners Inc. (PIII) reflects the market's valuation of cost management efficiency within Medicare Advantage. This multiple relates current market capitalization to the volume of generated revenue, determining the cost of each unit of sales. The calculation allows for the identification of whether the asset is overbought or if its operating margins are undervalued. This helps investors assess the business's resilience to fluctuations in medical expenses and the accuracy of the clinics' forecasting.

Main competitors

P/S Multiple hcahealthcare.com (HCA)|Market Capitalization-to-Revenue Ratio Tenet Healthcare Corporation|P/S Multiple Fresenius Medical Care AG FMS|SOLV (Solventum Inc.) - Price to Sales|EHC - P/S Multiple|UHS: P/S Multiple|DVA (davita.com) - Price-to-Revenue Ratio|Price-to-Revenue Ratio RadNet|Market Cap to Revenue Option Care (OPCH)|Market Cap to Sales Volume Surgery Partners Corp|P/S Multiple Premier Health (PINC)|Market Capitalization-to-Revenue Ratio National Vision Holdings|PGNY - Market Cap to Revenue|Market Capitalization-to-Revenue Ratio Ardent Health Partners (ARDT)|SEM: Price-to-Revenue Ratio|Price-to-Sales Ratio Apollo Medical Holdings (ASTH)|MEDNAX (MD) - P/S Multiple|USPH (US Physical Therapy) - P/S Multiple|Price-to-Revenue Ratio PNTG|Organogenesis (ORGO) - Market Capitalization-to-Revenue Ratio|Market Cap to Revenue Nutex Health Inc NUTX|Market Cap to Sales Volume Auna Health (AUNA)|SBC Medical Group Holdings - Price-to-Revenue Ratio|Evolus, Inc. (EOLS) - Market Cap to Revenue Ratio|CYH - P/S Multiple|Price to Sales SKIN|MDWD (MediWound) - Price-to-Revenue Ratio|BTMD - Market Capitalization-to-Revenue Ratio|Price-to-Revenue Ratio JYNT|DCGO (DocGo Inc.) - Price-to-Revenue Coefficient|Market Cap to Revenue gaintherapeutics.com GANX|Market Capitalization-to-Revenue Ratio EUDA Health Holdings Limited|P/S Multiple Basel Medical BMGL|Price-to-Revenue Coefficient CLGN (CollPlant Ltd)|CUPR: Price-to-Revenue Ratio|Market Cap to Revenue Ratio Concord Medical Services|ashs.com (AMS) - P/S Multiple|Market Cap to Revenue MRM|Market Cap to Revenue Avalon GloboCare Corporation (ALBT)|DHAI (DIH Holding US Inc.) - Price-to-Revenue Coefficient|Price-to-Revenue Ratio XAGE (Carmell Corp)|NewGenIvf Group Limited (NIVF) - Price-to-Sales Ratio|P/S Multiple ATI Physical Therapy Inc. ATIP|Price-to-Revenue Coefficient CMAX (CareMax)|KDLY - P/S Multiple|LogistiCare - Price-to-Revenue Coefficient|Novo Integrated Sciences Corp (NVOS) - P/S Multiple|SSY: Price-to-Revenue Coefficient|Market Cap to Revenue imacholdings.comm (BACK)